Search details
1.
Structure of the proton-gated urea channel from the gastric pathogen Helicobacter pylori.
Nature
; 493(7431): 255-8, 2013 Jan 10.
Article
in English
| MEDLINE | ID: mdl-23222544
2.
A nonazole CYP51 inhibitor cures Chagas' disease in a mouse model of acute infection.
Antimicrob Agents Chemother
; 54(6): 2480-8, 2010 Jun.
Article
in English
| MEDLINE | ID: mdl-20385875
3.
Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7.
J Biol Inorg Chem
; 15(2): 159-74, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-19727859
4.
Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53.
Nat Commun
; 4: 1407, 2013.
Article
in English
| MEDLINE | ID: mdl-23360998
5.
Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51.
PLoS Negl Trop Dis
; 6(7): e1736, 2012.
Article
in English
| MEDLINE | ID: mdl-22860142
6.
Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole.
PLoS Negl Trop Dis
; 4(4): e651, 2010 Apr 06.
Article
in English
| MEDLINE | ID: mdl-20386598
7.
Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit.
PLoS Negl Trop Dis
; 3(2): e372, 2009.
Article
in English
| MEDLINE | ID: mdl-19190730
8.
The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity.
J Biol Inorg Chem
; 13(5): 813-24, 2008 Jun.
Article
in English
| MEDLINE | ID: mdl-18392864
Results
1 -
8
de 8
1
Next >
>>